Data-driven mapping of known and novel fluid biomarker progression profiles in genetic frontotemporal lobar degeneration
The model’s accurate estimation of disease stages underscores the value of DEBM for patient stratification, offer a promising tool to support clinical trial design and provide a temporal ordering of multiple CSF proteins.